Back to Texas

HB4539 • 2025

Relating to the dispensing of certain drugs by physicians specializing in ophthalmology.

Relating to the dispensing of certain drugs by physicians specializing in ophthalmology.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Johnson | Frank | VanDeaver | Bonnen | Howard
Last action
2025-05-16
Official status
05/16/2025 S Referred to Health & Human Services
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Relating to the dispensing of certain drugs by physicians specializing in ophthalmology.

Relating to the dispensing of certain drugs by physicians specializing in ophthalmology.

What This Bill Does

  • Relating to the dispensing of certain drugs by physicians specializing in ophthalmology.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2025-05-16 Texas Legislature Online

    Read first time

  2. 2025-05-16 Texas Legislature Online

    Referred to Health & Human Services

  3. 2025-05-15 Texas Legislature Online

    Read 3rd time

  4. 2025-05-15 Texas Legislature Online

    Passed

  5. 2025-05-15 Texas Legislature Online

    Record vote. RV#2655

  6. 2025-05-15 Texas Legislature Online

    Statement(s) of vote recorded in Journal

  7. 2025-05-15 Texas Legislature Online

    Reported engrossed

  8. 2025-05-15 Texas Legislature Online

    Received from the House

  9. 2025-05-14 Texas Legislature Online

    Read 2nd time

  10. 2025-05-14 Texas Legislature Online

    Passed to engrossment

  11. 2025-05-14 Texas Legislature Online

    Record vote. RV#2546

  12. 2025-05-11 Texas Legislature Online

    Placed on General State Calendar

  13. 2025-05-09 Texas Legislature Online

    Considered in Calendars

  14. 2025-05-08 Texas Legislature Online

    Committee report sent to Calendars

  15. 2025-05-07 Texas Legislature Online

    Comte report filed with Committee Coordinator

  16. 2025-05-07 Texas Legislature Online

    Committee report distributed

  17. 2025-05-01 Texas Legislature Online

    Considered in formal meeting

  18. 2025-05-01 Texas Legislature Online

    Committee substitute considered in committee

  19. 2025-05-01 Texas Legislature Online

    Reported favorably as substituted

  20. 2025-04-28 Texas Legislature Online

    Scheduled for public hearing on . . .

  21. 2025-04-28 Texas Legislature Online

    Considered in public hearing

  22. 2025-04-28 Texas Legislature Online

    Committee substitute considered in committee

  23. 2025-04-28 Texas Legislature Online

    Testimony taken/registration(s) recorded in committee

  24. 2025-04-28 Texas Legislature Online

    Left pending in committee

  25. 2025-04-24 Texas Legislature Online

    Posting rule suspended

  26. 2025-04-03 Texas Legislature Online

    Read first time

  27. 2025-04-03 Texas Legislature Online

    Referred to Public Health

  28. 2025-03-12 Texas Legislature Online

    Filed

Official Summary Text

Relating to the dispensing of certain drugs by physicians specializing in ophthalmology.

Current Bill Text

Read the full stored bill text
89(R) HB 4539 - Engrossed version - Bill Text

89R18389 AND-F

By: Johnson, Frank, VanDeaver, Bonnen,

H.B. No. 4539

Howard

A BILL TO BE ENTITLED

AN ACT

relating to the dispensing of certain drugs by physicians

specializing in ophthalmology.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Section 157.002(f), Occupations Code, is amended

to read as follows:

(f) Subsections (b) and (c) do not authorize a physician or

a person acting under the supervision of a physician to keep a

pharmacy, advertised or otherwise, for the retail sale of dangerous

drugs, other than as authorized under Section 158.003
or 158.004
,

without complying with the applicable laws relating to the

dangerous drugs.

SECTION 2. Chapter 158, Occupations Code, is amended by

adding Section 158.004 to read as follows:

Sec.

158.004.

DISPENSING OF CERTAIN OPHTHALMIC DRUGS. (a)

In this section, "dangerous drug" and "dispense" have the meanings

assigned to those terms by Section 483.001, Health and Safety Code.

(b)

A physician specializing in ophthalmology may dispense

to the physician's patients commercially sealed and packaged

nonsystemic dangerous drugs in drop or ointment form for initial,

post-examination, post-procedural, or emergent ophthalmic

treatment.

(c)

A physician may charge and receive reimbursement for

stocking, storing, and labeling a drug dispensed under Subsection

(b) without obtaining a license under Chapter

558.

(d)

A physician who dispenses drugs under Subsection (b)

shall:

(1)

comply with each labeling provision under Subtitle

J applicable to that class of drugs; and

(2)

ensure compliance with packaging and

recordkeeping provisions applicable to that class of drugs.

SECTION 3. Section 551.004(b), Occupations Code, is amended

to read as follows:

(b) This subtitle does not prevent a practitioner from
:

(1)
administering a drug to a patient of the

practitioner
; or

(2)

dispensing dangerous drugs to a patient as

provided by Section 158.004
.

SECTION 4. Section 563.051(d), Occupations Code, is amended

to read as follows:

(d) This section does not authorize a physician or a person

acting under the supervision of a physician to keep a pharmacy,

advertised or otherwise, for the retail sale of dangerous drugs,

other than as authorized under Section 158.003
or 158.004
, without

complying with the applicable laws relating to the dangerous drugs.

SECTION 5. This Act takes effect immediately if it receives

a vote of two-thirds of all the members elected to each house, as

provided by Section 39, Article III, Texas Constitution. If this

Act does not receive the vote necessary for immediate effect, this

Act takes effect September 1, 2025.